Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of $65M in penalties
The US Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%. The justices turned away Shkreli’s appeal of a lower court’s decision upholding the penalty, equal to the profits he and one of … Read more